4th Quarter - Report

THE MCMANUS GROUP for NOVARTIS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Pharmaceutical coverage and access in Parts A, B, C, and D.

Foreign entity interest: Novartis AG, Fabrikstrasse 2, 4056 Basel, Switzerland

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Legislation and regulations affecting taxation of pharmaceutical products, including research and development and orphan drug tax credits. Protecting Americans From Tax Hikes Act of 2015.

Foreign entity interest: Novartis AG, Fabrikstrasse 2, 4056 Basel, Switzerland

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Education and advocacy regarding novel biopharmaceutical products. H.R.6 - 21st Century Cures Act.Advocacy and policy development regarding 340B.

Foreign entity interest: Novartis AG, Fabrikstrasse 2, 4056 Basel, Switzerland

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.